Mona F. El-Azab

980 total citations
37 papers, 790 citations indexed

About

Mona F. El-Azab is a scholar working on Molecular Biology, Oncology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Mona F. El-Azab has authored 37 papers receiving a total of 790 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Oncology and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Mona F. El-Azab's work include Chemotherapy-induced cardiotoxicity and mitigation (5 papers), Angiogenesis and VEGF in Cancer (4 papers) and Retinal Diseases and Treatments (3 papers). Mona F. El-Azab is often cited by papers focused on Chemotherapy-induced cardiotoxicity and mitigation (5 papers), Angiogenesis and VEGF in Cancer (4 papers) and Retinal Diseases and Treatments (3 papers). Mona F. El-Azab collaborates with scholars based in Egypt, United States and Saudi Arabia. Mona F. El-Azab's co-authors include Yasser M. Moustafa, Abdalla M. El‐Mowafy, Fadia M. Attia, Samar A. Antar, El‐Sayed El‐Awady, Azza B. El‐Remessy, Mohammed M.H. Al-Gayyar, Barbara A. Mysona, Belal H.M. Hussein and Mohammed Abdelsaid and has published in prestigious journals such as The FASEB Journal, Diabetologia and British Journal of Pharmacology.

In The Last Decade

Mona F. El-Azab

37 papers receiving 780 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mona F. El-Azab Egypt 18 306 86 80 79 77 37 790
Zheng Xu China 18 488 1.6× 76 0.9× 41 0.5× 74 0.9× 98 1.3× 35 1.1k
Ahsas Goyal India 18 548 1.8× 33 0.4× 61 0.8× 58 0.7× 52 0.7× 106 1.2k
Yusuke Miyazaki Japan 18 401 1.3× 232 2.7× 95 1.2× 55 0.7× 56 0.7× 49 880
Ahmed S. Ibrahim Egypt 21 487 1.6× 32 0.4× 49 0.6× 46 0.6× 63 0.8× 64 1.5k
Ying Yin China 19 496 1.6× 27 0.3× 66 0.8× 80 1.0× 124 1.6× 45 1.1k
Basim Anwar Shehata Messiha Egypt 21 251 0.8× 28 0.3× 47 0.6× 71 0.9× 79 1.0× 50 953
Xin Han China 20 460 1.5× 40 0.5× 26 0.3× 87 1.1× 99 1.3× 59 1.1k
So Young Eun South Korea 19 472 1.5× 34 0.4× 36 0.5× 100 1.3× 48 0.6× 36 857

Countries citing papers authored by Mona F. El-Azab

Since Specialization
Citations

This map shows the geographic impact of Mona F. El-Azab's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mona F. El-Azab with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mona F. El-Azab more than expected).

Fields of papers citing papers by Mona F. El-Azab

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mona F. El-Azab. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mona F. El-Azab. The network helps show where Mona F. El-Azab may publish in the future.

Co-authorship network of co-authors of Mona F. El-Azab

This figure shows the co-authorship network connecting the top 25 collaborators of Mona F. El-Azab. A scholar is included among the top collaborators of Mona F. El-Azab based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mona F. El-Azab. Mona F. El-Azab is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mostafa, Yasser M., Eman T. Mehanna, Mona F. El-Azab, et al.. (2022). Pioglitazone Ameliorates Hippocampal Neurodegeneration, Disturbances in Glucose Metabolism and AKT/mTOR Signaling Pathways in Pentyelenetetrazole-Kindled Mice. Pharmaceuticals. 15(9). 1113–1113. 5 indexed citations
2.
3.
Youssef, Mahmoud E., Mahmoud M. El‐Mas, Heba M. A. Abdelrazek, & Mona F. El-Azab. (2021). α7-nAChRs-mediated therapeutic angiogenesis accounts for the advantageous effect of low nicotine doses against myocardial infarction in rats. European Journal of Pharmacology. 898. 173996–173996. 12 indexed citations
4.
Youssef, Mahmoud E., Mona F. El-Azab, Marwa A. Abdel-Dayem, et al.. (2021). Electrocardiographic and histopathological characterizations of diabetic cardiomyopathy in rats. Environmental Science and Pollution Research. 29(17). 25723–25732. 29 indexed citations
5.
El-Azab, Mona F., et al.. (2021). Inhibition of thioredoxin-interacting protein and inflammasome assembly using verapamil mitigates diabetic retinopathy and pancreatic injury. European Journal of Pharmacology. 901. 174061–174061. 24 indexed citations
6.
Moustafa, Yasser M., et al.. (2018). Neuroprotective mechanisms of sildenafil and selenium in PTZ-kindling model: Implications in epilepsy. European Journal of Pharmacology. 833. 131–144. 40 indexed citations
7.
El-Azab, Mona F., et al.. (2014). Protective effect of S-methyl cysteine against tilmicosin-induced cardiotoxicity in rats.. Pakistan Veterinary Journal. 34(3). 337–340. 7 indexed citations
8.
El-Azab, Mona F., et al.. (2014). Ameliorative effect of acetyl-l-carnitine and/or nifedipine against selenite-induced cataractogenesis in young albino rats. European Journal of Pharmacology. 729. 1–9. 5 indexed citations
9.
Shanab, Ahmed Y., Sally L. Elshaer, Mona F. El-Azab, et al.. (2014). Candesartan stimulates reparative angiogenesis in ischemic retinopathy model: role of hemeoxygenase-1 (HO-1). Angiogenesis. 18(2). 137–150. 17 indexed citations
10.
Moustafa, Yasser M., et al.. (2013). 15-PGDH inhibitors: the antiulcer effects of carbenoxolone, pioglitazone and verapamil in indomethacin induced peptic ulcer rats.. PubMed. 17(15). 2000–9. 5 indexed citations
11.
El-Azab, Mona F., Barbara A. Mysona, Ahmed Y. Shanab, et al.. (2013). Deletion of thioredoxin‐interacting protein preserves retinal neuronal function by preventing inflammation and vascular injury. British Journal of Pharmacology. 171(5). 1299–1313. 48 indexed citations
12.
Mysona, Barbara A., Mohammed M.H. Al-Gayyar, Suraporn Matragoon, et al.. (2013). Modulation of p75NTR prevents diabetes- and proNGF-induced retinal inflammation and blood–retina barrier breakdown in mice and rats. Diabetologia. 56(10). 2329–2339. 53 indexed citations
13.
14.
15.
El-Azab, Mona F. & Yasser M. Moustafa. (2012). Influence of calcium channel blockers on anticonvulsant and antinociceptive activities of valproic acid in pentylenetetrazole-kindled mice. Pharmacological Reports. 64(2). 305–314. 29 indexed citations
16.
Hussein, Belal H.M., et al.. (2012). A novel anti-tumor agent, Ln(III) 2-thioacetate benzothiazole induces anti-angiogenic effect and cell death in cancer cell lines. European Journal of Medicinal Chemistry. 51. 99–109. 39 indexed citations
17.
El-Azab, Mona F., Barbara A. Mysona, & Azza B. El‐Remessy. (2011). Statins for prevention of diabetic-related blindness: a new treatment option?. Expert Review of Ophthalmology. 6(3). 269–272. 8 indexed citations
18.
El‐Mowafy, Abdalla M., Hatem A. Salem, Mohammed M.H. Al-Gayyar, Mohamed El‐Mesery, & Mona F. El-Azab. (2011). Evaluation of renal protective effects of the green-tea (EGCG) and red grape resveratrol: role of oxidative stress and inflammatory cytokines. Natural Product Research. 25(8). 850–856. 45 indexed citations
19.
El-Azab, Mona F., et al.. (2010). Anti-angiogenic effect of resveratrol or curcumin in Ehrlich ascites carcinoma-bearing mice. European Journal of Pharmacology. 652(1-3). 7–14. 67 indexed citations
20.
Shokeir, Ahmed A., et al.. (1997). Renal Doppler ultrasonography in children with equivocal obstructive uropathy: effect of intravenous normal saline fluid load and frusemide. British Journal of Urology. 80(2). 313–318. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zheng Xu Breakdown of academic impact, for papers by Ahsas Goyal Breakdown of academic impact, for papers by Yusuke Miyazaki Breakdown of academic impact, for papers by Ahmed S. Ibrahim Breakdown of academic impact, for papers by Ying Yin Breakdown of academic impact, for papers by Basim Anwar Shehata Messiha Breakdown of academic impact, for papers by Xin Han Breakdown of academic impact, for papers by So Young Eun
Rankless by CCL
2026